Investing Profile

Sakae Asanuma

InvestorVC
President & CEO at Taiho Ventures
taihoventures.com/team.htmlSan Francisco, California
Photo of Sakae Asanuma, President at Taiho Ventures
Your Intro Paths to Sakae Asanuma

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →

Find Sakae Asanuma on

cb
Current Investing Position
Taiho Ventures President
Investment Range
$100K - $5.0M
Sweet Spot
$1.5M
Investments On Record
11
Current Fund Size
$150M

Sakae Asanuma is on these Sector & Stage Rankings

Sakae Asanuma's Investments On Record (7)

CompanyStageDateRound SizeTotal Raised
Anavo Therapeutics
SeedMay 2023$9M
SeedApr 2021$24M
$33M
Co-investors: Therese Liechtenstein (M Ventures (Merck)), Debora Dumont (Bioqube Ventures), Simone Botti (INKEF Capital)
Cellvie
SeedFeb 2023$6M
$6M
Dren Bio
Series BJun 2022$65M
Series AOct 2020$60M
$130M
Co-investors: Andrew Schiff (Aisling Capital), Rajeev Dadoo (SR One), Chandra Leo (Hbm Partners)
Axial Biotherapeutics
Series COct 2021$37M
Series BJun 2019$10M
$86M
Co-investors: Nora Frey (Seventure Partners), Rich Aldrich (Longwood Fund), James Blair (Domain Associates)
Orna Therapeutics
Series AFeb 2021$80M
$320M
Co-investors: Ansbert Gadicke (MPM Capital), Shinichiro Fuse
Theolytics
Series AJan 2021$7M
$7M
Co-investors: Therese Liechtenstein (M Ventures (Merck))
Storm Therapeutics
Series AMay 2019$18M
Series AJan 2018$5M
$69M
Co-investors: Bruno Montanari (Seroba Life Sciences), Hakan Goker (M Ventures (Merck))